Deerfield, Illinois-based company in June said it would close
about 200 stores in the United Kingdom as performance in its UK
Boots business continued to lag in the latest reported quarter.
The store closures are part of the company's cost management
program that is aimed at mitigating the pressure related to
generic drug prices, the company had said in June.
The program is expected to deliver annual cost savings in excess
of $1.5 billion by 2022, the company said in a regulatory filing
https://bit.ly/2YJYG6U on Tuesday.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by
[© 2019 Thomson Reuters. All rights
Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.